Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 1/20 | 0.48 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.48 |
| ▸ | OPRM1 | P35372 | 13/20 | 0.45 |
| ▸ | GRIN1 | Q05586 | 1/20 | 0.42 |
| ▸ | GRIN2B | Q13224 | 1/20 | 0.42 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.42 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.42 |
| ▸ | SLC6A4 | P31645 | 2/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.42 |
| ▸ | OPRK1 | P41145 | 2/20 | 0.41 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.41 |
| ▸ | SLC22A1 | O15245 | 1/20 | 0.40 |
| ▸ | PRCP | P42785 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4913374 | 0.77 | KMT2A (0.56) | OPRM1OPRK1OPRD1 | |
| SCHEMBL1014404 | 0.75 | S1PR5 (0.50) | GRIN2BSIGMAR1 | |
| SCHEMBL4687584 | 0.75 | LMNA (0.60) | — | |
| SCHEMBL4686638 | 0.75 | LMNA (0.60) | — | |
| SCHEMBL6072947 | 0.73 | HHAT (0.47) | GRIN1GRIN2BSIGMAR1 | |
| SCHEMBL11104021 | 0.72 | TSHR (0.66) | TSHRNPSR1OPRM1SLC6A2SLC6A4 | |
| SCHEMBL4650250 | 0.72 | CFTR (0.43) | NPSR1OPRM1OPRK1OPRD1 | |
| Hydrochloric Acid SCHEMBL11481488 | 0.71 | TSHR (0.68) | TSHRNPSR1OPRM1SLC6A2SLC6A4 | |
| SCHEMBL5160890 | 0.70 | TSHR (0.67) | TSHRNPSR1OPRM1SLC6A2SLC6A4 | |
| SCHEMBL32689446 | 0.70 | TSHR (0.67) | TSHRNPSR1OPRM1SLC6A2SLC6A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080255188-A1 | Muscarinic Receptor Antagonists | RANBAXY LABORATORIES LIMITED (IN) | 2008-10-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080255188-A1 | Muscarinic Receptor Antagonists | CHRM3, CHRM5, CHRM2 | TSHR 135/4885NPSR1 121/4885OPRM1 78/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.